257 related articles for article (PubMed ID: 5135408)
21. [Hyperlipidemia and other risk factors in coronary sclerosis].
Klör HU; Märtens HR; van Eimeren W; Härich B; Ditschuneit H
Arzneimittelforschung; 1972 Oct; 22(10):1808-10. PubMed ID: 4678569
[No Abstract] [Full Text] [Related]
22. Familial type IV hyperlipoproteinemia.
Schreibman PH; Wilson DE; Arky RA
N Engl J Med; 1969 Oct; 281(18):981-5. PubMed ID: 5824739
[No Abstract] [Full Text] [Related]
23. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
24. [Lipids and arteriosclerosis].
Carmena R
Rev Clin Esp; 1973 Aug; 130(3):181-94. PubMed ID: 4201566
[No Abstract] [Full Text] [Related]
25. [Serum lipids, lipoproteins and coronary disease].
Nikkilä EA
Duodecim; 1972; 88(21):1271-82. PubMed ID: 4656210
[No Abstract] [Full Text] [Related]
26. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
[No Abstract] [Full Text] [Related]
27. Perifollicular xanthomatosis.
Pirozzi DJ; Gross PR
Arch Dermatol; 1971 Oct; 104(4):431-3. PubMed ID: 5114417
[No Abstract] [Full Text] [Related]
28. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
Nye ER; Jackson D; Hunter JD
N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
[No Abstract] [Full Text] [Related]
29. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
Roe DA
Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
[No Abstract] [Full Text] [Related]
30. Type 3 hyperlipoproteinaemia.
Borrie P
Br Med J; 1969 Jun; 2(5658):665-7. PubMed ID: 5783124
[TBL] [Abstract][Full Text] [Related]
31. Familial hyperuricaemia and hypertriglyceridaemia.
Bennett RM; Chait A; Lewis B
Ann Rheum Dis; 1973 Nov; 32(6):497-500. PubMed ID: 4760474
[No Abstract] [Full Text] [Related]
32. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
Bornemisza P; Csögör I
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
[No Abstract] [Full Text] [Related]
33. [Mixed hyperlipemia with a distinct accumulation of beta and prebeta lipoproteins (apropos of 78 cases)].
Loeper J; Rouffy J; Loeper J
Arch Mal Coeur Vaiss; 1970-1971; 12():Suppl 1:3-15. PubMed ID: 5004789
[No Abstract] [Full Text] [Related]
34. [Classification of hyperlipoproteinemias].
Zabel R
Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
[No Abstract] [Full Text] [Related]
35. Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia).
Khachadurian AK
Arthritis Rheum; 1968 Jun; 11(3):385-93. PubMed ID: 5657441
[No Abstract] [Full Text] [Related]
36. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
[No Abstract] [Full Text] [Related]
37. Type III hyperlipoproteinaemia: the turnover rate of plasma triglycerides and the response to clofibrate.
Stuyt PM; Demacker PN; Stalenhoef AF; Schade RW; Lutterman JA; van't Laar A
Neth J Med; 1982; 25(8):245-54. PubMed ID: 7144991
[No Abstract] [Full Text] [Related]
38. The dyslipoproteinemias.
Brown DF
Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():18-52. PubMed ID: 4369284
[No Abstract] [Full Text] [Related]
39. Polyneuropathy associated with hyperlipemia.
Bechar M; Kott E; Bornstein B
Confin Neurol; 1969; 31(5):281-8. PubMed ID: 5383223
[No Abstract] [Full Text] [Related]
40. [Blood lipoproteins and the skin].
Holasek A
Z Haut Geschlechtskr; 1971 Oct; 46(19):673-4. PubMed ID: 5137248
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
